Main programme

>> Monday >> Tuesday >> Wednesday




Monday 03 July 2017

08:30 - 09:30
Invited session 01: Keynote session
08:30 - 09:00
Human Reproduction keynote lecture - Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study
Carlos Simon Valles, Spain
09:00 - 09:30
Non-invasive prenatal testing (NIPT) - state of the art
Dennis Lo, Hong Kong

09:30 - 10:00
Coffee break (in the exhibit hall)

10:00 - 11:30
6 parallel selected oral communication sessions

11:45 - 12:45
Invited session 02: Ovarian rejuvenation: for real or just a dream?
11:45 - 12:15
Mitochondrial transfer- can it improve oocyte quality?
Jacques Cohen, U.S.A.
12:15 - 12:45
Improving ovarian response through ovarian tissue activation
Kazuhiro Kawamura, Japan

11:45 - 12:45
Invited session 03: Data reporting session (PGD Consortium)
11:45 - 12:15
Data from the ESHRE PGD Consortium
Martine De Rycke, Belgium
12:15 - 12:45
Data from ESTEEM
Karen Sermon, Belgium

11:45 - 12:15
Invited session 04: Fertility Society of Australia Exchange Lecture
11:45 - 12:15
New strategies for ovarian preservation during cancer treatment: Elimination of PUMA confers protection against chemotherapy-mediated oocyte loss
Quynh-nhu Nguyen, Australia

11:45 - 12:45
Invited session 05: Paramedical invited session 1: Sperm messaging - what's the story?
11:45 - 12:15
Genetic screening in cases of extreme poor spermatogenesis
Liliana Ramos, The Netherlands
12:15 - 12:45
Evaluating oocyte activation potential of sperm using calcium pattern analysis
Bjorn Heindryckx, Belgium

11:45 - 13:00
Industry sponsored symposium 1

13:00 - 14:00
Lunch break (in the exhibit hall)

14:00 - 15:00
Invited session 06: The science and ethics behind germline genome editing
14:00 - 14:30
Gene editing in the human germ line - risks and possibilities
Robin Lovell-Badge, United Kingdom
14:30 - 15:00
Should we edit the genomes of our future children?
Stephen Wilkinson, United Kingdom

14:00 - 15:00
Invited session 07: Recent developments in ovarian (hyper) stimulation and ovulation induction
14:00 - 14:30
Individualised ovarian stimulation for IVF: balancing cumulative outcome, safety, burden and costs
Anders Nyboe Andersen, Denmark
14:30 - 15:00
The evolution of treatment approaches in PCOS: management of ovulation and metabolism
Richard Anderson, United Kingdom

14:00 - 15:00
Invited session 08: Debate: Deep endometriosis: to operate or not in infertile women
14:00 - 14:30
Pro
Horace Roman, France
14:30 - 15:00
Con
Fran├žois Golfier, France

14:00 - 15:00
Paramedical selected oral communication session

14:00 - 15:15
Industry sponsored symposium 2

15:15 - 16:30
6 parallel selected oral communication sessions

16:30 - 17:00
Coffee break (in the exhibit hall)

17:00 - 18:00
Invited session 09: Has transcriptome analysis of oocytes and embryos run its course? Single cell omics
17:00 - 17:30
Single-cell proteomics of human oocytes
Jeroen Krijgsveld, Germany
17:30 - 18:00
Deciphering developmental processes from single-cell transcriptomes
Paul Robson, U.S.A.

17:00 - 18:00
Invited session 10: Are microwave food containers, water bottles and soft drink cans making you infertile?
17:00 - 17:30
Plasticizers and male fertility
Richard Sharpe, United Kingdom
17:30 - 18:00
Plastics and miscarriage
Ruth Lathi, U.S.A.

17:00 - 18:00
Invited session 11: Changing the life course for PCOS
17:00 - 17:30
PCOS in adolescence-to diagnose or not and future fate
Kathy Hoeger, U.S.A.
17:30 - 18:00
Is there a need to increase PCOS awareness?
Helena Teede, Australia

17:00 - 18:00
Paramedical selected oral communication session

17:00 - 18:15
Industry sponsored symposium 3